Atherogenic dyslipidemia in patients with transient ischemic attack

Gaia Sirimarco¹, Dominique Deplanque, Philippa C Lavallée

¹INSERM U-698 and Paris-Diderot University, Department of Neurology and Stroke Centre, Bichat University Hospital, Paris, France.

|July 9, 2011

Summary

This study examined atherogenic dyslipidemia in patients who had a transient ischemic attack (TIA). Atherogenic dyslipidemia refers to low HDL cholesterol and high triglycerides. Researchers found this condition was present in about 5.8% of TIA patients. It was linked to male sex, diabetes, and higher body mass index. The condition also correlated with intracranial artery stenosis ≥ 50%. Patients with atherogenic dyslipidemia had a higher 90-day stroke risk. Despite treatment, they were more likely to experience a recurrence. The study suggests this lipid profile may be a risk marker for TIA patients. Further research is needed to confirm these findings and guide treatment strategies.

Area of Science:

Cardiovascular disease epidemiology
Neurological stroke risk assessment
Lipid metabolism in cerebrovascular disorders

Background:

Atherogenic dyslipidemia is increasingly recognized as a cardiovascular risk factor. Prior research has shown its link to stroke and heart disease. However, its role in transient ischemic attack (TIA) remains unclear. Established knowledge includes its association with diabetes and obesity. No prior work had resolved its specific impact on TIA recurrence. This gap motivated a closer look at TIA patients. The SOS-TIA cohort study aimed to address this uncertainty. It focused on lipid profiles in TIA patients. This paper's contribution is to explore atherogenic dyslipidemia's role in TIA outcomes.

Purpose Of The Study:

The study aimed to evaluate the prevalence of atherogenic dyslipidemia in TIA patients. It also sought to determine if this lipid profile correlates with stroke risk. The SOS-TIA cohort was used to assess this. Researchers wanted to identify factors linked to this dyslipidemia. They focused on intracranial stenosis and recurrence risk. The goal was to inform better secondary prevention strategies. This work aimed to clarify residual risk in TIA patients. It sought to guide future treatment approaches.

Main Methods:

The SOS-TIA cohort included 1471 patients with TIA or minor stroke. Participants underwent standardized evaluations. Blood tests were conducted under fasting conditions. Atherogenic dyslipidemia was defined as HDL ≤ 40 mg/dL and triglycerides ≥ 150 mg/dL. Medical history and diagnostic testing were also collected. Follow-up occurred over a 1-year period. Researchers assessed associations with intracranial stenosis. They used statistical models to adjust for confounding factors.

Main Results:

Atherogenic dyslipidemia was present in 5.8% of TIA patients. Prevalence varied by diagnosis, from 4.6% to 11.1%. It was independently linked to male sex and diabetes. Body mass index also showed a strong association. The condition correlated with intracranial stenosis ≥ 50%. Adjusted odds ratio was 2.77 (95% CI, 1.38-5.55). Stroke recurrence risk at 90 days was higher in affected patients. Risk was 4.8% versus 1.7% (P=0.04) in non-affected individuals.

Conclusions:

The study suggests atherogenic dyslipidemia may be linked to intracranial stenosis in TIA patients. It may also increase early stroke recurrence risk. These findings are based on the SOS-TIA cohort data. Researchers propose that this dyslipidemia is a relevant risk marker. They emphasize the need for further validation of these associations. No prior work had resolved the best treatment for affected patients. The authors suggest additional data are needed to guide prevention. They highlight residual risk in TIA patients with this lipid profile.

Keywords:

atherogenic dyslipidemia TIA risk factors lipid profile stroke intracranial stenosis

Frequently Asked Questions

Atherogenic dyslipidemia is defined as HDL ≤ 40 mg/dL and triglycerides ≥ 150 mg/dL. The study found it may increase early stroke recurrence risk in TIA patients.

It was defined as HDL cholesterol ≤ 40 mg/dL and triglycerides ≥ 150 mg/dL measured under fasting conditions.

The researchers wanted to determine if atherogenic dyslipidemia correlates with intracranial stenosis ≥ 50% in TIA patients.

Higher body mass index was independently associated with atherogenic dyslipidemia in TIA patients.

The 90-day stroke risk was 4.8% in patients with atherogenic dyslipidemia versus 1.7% in those without.

The authors propose additional data are needed to confirm findings and guide treatment for residual risk in TIA patients with this lipid profile.

Related Concept Videos